Cost-effectiveness of empagliflozin as a treatment for heart failure with reduced ejection fraction: an analysis from the Chinese healthcare perspective
@article{JTD64749,
author = {Xiaohui Lin and Minhua Lin and Maobai Liu and Weiying Huang and Xuekun Nie and Zichun Chen and Bin Zheng},
title = {Cost-effectiveness of empagliflozin as a treatment for heart failure with reduced ejection fraction: an analysis from the Chinese healthcare perspective},
journal = {Journal of Thoracic Disease},
volume = {14},
number = {5},
year = {2022},
keywords = {},
abstract = {},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/64749}
}